Keck School of Medicine (University of Southern California)
One out of every 50 Americans have glaucoma, which if left untreated can cause vision loss and blindness. Dr. Varma is a leading authority in the diagnosis and treatment of this disease. Dr. Varma is a board-certified ophthalmologist and a member of the American Academy of Ophthalmology, American Society of Cataract & Refractive Surgery and the Floater and Drusen Association. He is one of the few surgeons in the country to have completed fellowship training at UCLA's Doheny Eye Institute, where he honed his skills as an expert laser eye surgeon. He has pioneered numerous techniques for cataract and refractive surgeries, and is sought out by patients from all over Southern California who are looking for a top-rated glaucoma specialist to help them manage this Glaucoma is a group of eye diseases that damage the optic nerve, which conveys light from the eye to the brain. If severe glaucoma is undetected and/or uncontrolled, it can lead to blindness.
Dr. Rohit Varma USC has made revolutionary advances in establishing the mechanisms of glaucomatous optic nerve damage. His work focuses on studying new imaging techniques that could be used in early diagnosis. This work may lead to reduced vision loss in persons with glaucoma around the world. Rohit Varma, MD, PhD, FAAP, is a leading expert in pediatric ophthalmology and epidemiology. He was among the first investigators to report the epidemiologic findings of an association between myopia and educational attainment and subsequently identified the high prevalence of myopia in youth of Asian descent who have migrated to the United States and Canada. His research focuses on understanding and managing intraocular pressure. He and his colleagues developed the implantable contact lens that is implanted in the eye to manage glaucoma. In this book, Dr. Rohit Varma provides the reader with a deep understanding of how the eye works, and explains why people with vision loss experience certain symptoms. With his clear, un-jargon laden explanations, he guides the eye care professional and patient through current vision research and the known pharmacological options for treating a range of retinal diseases and disorders. He completed basic science and clinical residency training at the University of Chicago, including a glaucoma specialty fellowship and additional research training at Illinois Eye and Ear Infirmary, College of Medicine, University of Illinois at Chicago. Rohit Varma was appointed president and CEO of Southern California. SCEI also includes 3 hospitals and 25 primary care medical residences. Dr. Varma is Board Certified in Ophthalmology. He also received a Master of Science in Clinical Investigation from Baylor College of Medicine and completed a Fellowship at Wills Eye Hospital, Philadelphia Pennsylvania in Cornea & External Disease, Glaucoma and Refractive Surgery.
0 Comments
Leave a Reply. |
AuthorOver the course of his career as a clinical scientist, Rohit Varma served as the lead researcher for many trials sponsored by the Health Foundation and the Department of Health. As an international expert in population-based eye diseases, his organizations and leadership of the Los Angeles Latino Eye Study, the Chinese American Eye Study, the Multiethnic Pediatric Eye Disorders Study, as well as the African American Eye Disease Study, helped him gain renown. His research has had a significant influence on U.S. health policy, notably with respect to primary care among numerous racial and ethnic groups. ArchivesCategories |